Patients who achieved a pathologic complete response after neoadjuvant therapy had better survival outcomes than patients who received adjuvant therapy.

In the years since targeted treatments for CLL were introduced, their use in the second line has increased, but chemotherapy regimens remain the most common first-line treatment in these patients.

(HealthDay News) — Most Americans don’t plan to get vaccinated against the flu or COVID-19 this season, according to a survey from the National Foundation for Infectious Diseases (NFID).

The incidence of cardiovascular disease is higher in older adults with cancer, especially those with hematologic, lung, and metastatic cancers.

Survey results suggest that cancer patients want financial toxicity screening to occur early, but screening preferences and practices vary.

(HealthDay News) — A wearable device may improve physical activity, physical function, dyspnea, and pain after lung cancer surgery, according to a study published in JAMA Network Open.

Multiple myeloma patients with COVID-19 have high rates of hospitalization, ICU admission, and death, according to researchers.

Radiopharmaceuticals have been used to treat patients with prostate cancer for decades, but experts say there is more to learn about these agents.

Researchers sought to determine the effect of antibiotics on the risk of colorectal cancer recurrence after surgery.

Trimodal therapy may be an effective alternative to radical cystectomy for recurrent, high-grade T1 bladder cancer, according to a study published in the Journal of Clinical Oncology.

Americans have the worst health care among the world’s wealthy nations, according to a report from health care think-tank The Commonwealth Fund. The report showed that people in the United States die ...

Adding PD-(L)1 inhibitors to chemotherapy improved outcomes, but PD-(L)1 inhibitors alone were no more effective than chemotherapy alone in patients with gastric, gastroesophageal junction, and ...